Improving the quality of cancer clinical trials
Subtitle: workshop summary
By: National Cancer Policy Forum, Margie Patlack and Sharyl Nass, Rapporteurs.
Contributors: Patlak, Margie.; Nass, Sharyl J.; National Cancer Policy Forum (U.S.); Institute of Medicine (U.S.)
Publisher: National Academies Press
Published: 2008
Place of publication: Washington, D.C
Language: eng
Number of pages: 124
ISBN-13: 9780309116688
Subjects: Cancer -- Treatment -- United States; Clinical trials
Notes: Includes bibliographical references.

Also available on the World Wide Web.
Table of contents: title: Introduction; title: New clinical trial designs. Phase 0 trials; title: Adaptive trial designs; title: Targeting multiple pathways with multiple drugs; title: Preclinical model systems; title: Molecular imaging. Current and developing methods; title: Challenges of molecular imaging; title: Screening for predictive markers. The challenges of clinical validation; title: Bioimaging predictive markers; title: Clinical translation; title: Panel discussion; title: Costs of clinical trials. Regulatory costs; title: Patient accrual; title: Global outsourcing; title: Time is money; title: Public-private collaborations; title: Regulatory issues. Regulatory barriers to innovation; title: Patient advocacy perspective; title: Regulation of in vitro diagnostics; title: Regulatory issues in improving cancer clinical trials; title: Reports from the case study discussion groups. Adaptive trial design; title: Phase 0 trials; title: Imaging; title: Use of proteomics/genomics to assign therapy in lung cancer; title: Use of genetics/genomics to assign therapy.